Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Brigid S Boland
Affiliation
University of California
ORCID
Career Start Year
2005
Papers
100
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38052229
Reverse metabolomics for the discovery of chemical structures from humans.
Nature
2024
38052229
Reverse metabolomics for the discovery of chemical structures from humans.
Nature
2024
36343846
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
2023
35704691
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.
Inflamm Bowel Dis
2023
35644340
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
2023
36343846
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
2023
36191274
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Am J Gastroenterol
2023
37853256
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.
Nat Biotechnol
2023
37648857
Metabolic programs of T cell tissue residency empower tumour immunity.
Nature
2023
37268795
Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
Dig Dis Sci
2023
36623171
Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease.
Am J Gastroenterol
2023
37061107
HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
2023
36993763
A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics.
bioRxiv
2023
37235748
Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
Inflamm Bowel Dis
2023
36854061
Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's Disease.
Clin Transl Gastroenterol
2023
36986672
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
Pharmaceutics
2023
36669515
Management of inflammatory bowel diseases in older adults.
Lancet Gastroenterol Hepatol
2023
36662860
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy.
Sci Adv
2023
37224198
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
2023
37853256
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.
Nat Biotechnol
2023
37648857
Metabolic programs of T cell tissue residency empower tumour immunity.
Nature
2023
35704691
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.
Inflamm Bowel Dis
2023
35644340
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Clin Gastroenterol Hepatol
2023
37061107
HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
2023
36993763
A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics.
bioRxiv
2023
36986672
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
Pharmaceutics
2023
37235748
Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
Inflamm Bowel Dis
2023
37268795
Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
Dig Dis Sci
2023
37224198
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
2023
36854061
Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's Disease.
Clin Transl Gastroenterol
2023
36623171
Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease.
Am J Gastroenterol
2023
36669515
Management of inflammatory bowel diseases in older adults.
Lancet Gastroenterol Hepatol
2023
36662860
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy.
Sci Adv
2023
36191274
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Am J Gastroenterol
2023
33039584
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
2022
35973139
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Am J Gastroenterol
2022
35798960
Enhancing untargeted metabolomics using metadata-based source annotation.
Nat Biotechnol
2022
33556578
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
2022
33039584
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
2022
35347100
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.
Clin Transl Gastroenterol
2022
35798960
Enhancing untargeted metabolomics using metadata-based source annotation.
Nat Biotechnol
2022
35347100
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.
Clin Transl Gastroenterol
2022
35973139
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Am J Gastroenterol
2022
33556578
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
2022
32348905
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
2021
32348905
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
2021
33745174
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply.
Aliment Pharmacol Ther
2021
33744307
Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
Gastroenterology
2021
33555517
Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
Dig Dis Sci
2021
33252124
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.
Inflamm Bowel Dis
2021
1 - 50 of 200
Column Actions
Search
Recommended Authors
Terrence C Lee
University of California San Diego
Career Start Year
2013
Number of shared co-authors
0
Anouar Teriaky
Western University
Career Start Year
2011
Number of shared co-authors
3
Trilokesh D Kidambi
City of Hope National Medical Center
Career Start Year
2010
Number of shared co-authors
0
Mark Asquith
Oregon Health and Science University
Career Start Year
2010
Number of shared co-authors
4
Rafia Bhore
Regeneron Pharmaceuticals
Career Start Year
2009
Number of shared co-authors
0
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year
2009
Number of shared co-authors
2
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year
2009
Number of shared co-authors
9
Brendan Boyle
Nationwide Children's Hospital
Career Start Year
2009
Number of shared co-authors
6
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year
2006
Number of shared co-authors
3
Michael Sey
Western University
Career Start Year
2006
Number of shared co-authors
3
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Career Start Year
2005
Number of shared co-authors
9
Daniel J Stein
Brigham and Women's Hospital
Career Start Year
2005
Number of shared co-authors
0
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year
2004
Number of shared co-authors
8
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year
2004
Number of shared co-authors
4
Eran Elinav
German Cancer Research Center
Career Start Year
2002
Number of shared co-authors
5
Elie Aoun
Columbia University
Career Start Year
2002
Number of shared co-authors
3
Jonathan P Jacobs
David Geffen School of Medicine at university of california los angeles
Career Start Year
2002
Number of shared co-authors
10
Ajay Bansal
Regeneron Pharmaceuticals Inc.
Career Start Year
2000
Number of shared co-authors
0
Florian Grimpen
Royal Brisbane and Women's Hospital
Career Start Year
2000
Number of shared co-authors
0
Jonas F Ludvigsson
Karolinska Institutet
Career Start Year
2000
Number of shared co-authors
3
William A Faubion
Mayo Clinic
Career Start Year
1997
Number of shared co-authors
14
Andrew T Chan
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1994
Number of shared co-authors
8
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year
1992
Number of shared co-authors
1
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year
1992
Number of shared co-authors
12
Michael Vieth
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Career Start Year
1991
Number of shared co-authors
2
Danielle K Turgeon
The University of Michigan ann arbor
Career Start Year
1990
Number of shared co-authors
0
Athos Bousvaros
Boston Children's Hospital
Career Start Year
1985
Number of shared co-authors
8
Felicity T Enders
Mayo Clinic
Career Start Year
1985
Number of shared co-authors
5
Nicholas J Talley
University of Newcastle
Career Start Year
1984
Number of shared co-authors
3
Ryan Balfour Sartor
University of North Carolina at Chapel Hill
Career Start Year
1981
Number of shared co-authors
15
row(s) 1 - 30 of 30
Collaborators
William J Sandborn
University of California San Diego
Co-authored papers
67
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers
54
Siddharth Singh
University of California San Diego
Co-authored papers
51
John T Chang
University of California San Diego
Co-authored papers
26
Sunanda V Kane
Mayo Clinic
Co-authored papers
15
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers
13
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers
13
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers
13
Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers
12
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers
12
Arun Swaminath
Lenox Hill Hospital
Co-authored papers
12
David Hudesman
NYU Grossman School of Medicine
Co-authored papers
12
Mark A Valasek
Co-authored papers
11
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers
11
Eugenia Shmidt
University of Minnesota
Co-authored papers
11
Robert Hirten
Co-authored papers
10
Nghia H Nguyen
University of California
Co-authored papers
9
Uma Mahadevan
University of California San Francisco
Co-authored papers
8
Pieter C Dorrestein
Co-authored papers
6
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers
6
Samuel B Ho
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Co-authored papers
6
Jocelyn G Olvera
Co-authored papers
5
Dermot P B McGovern
F. Widjaja Inflammatory Bowel Disease Institute
Co-authored papers
5
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers
5
Farhad Peerani
University of Alberta
Co-authored papers
5
Alan K Jarmusch
Co-authored papers
4
Pedro Belda-Ferre
University of California San Diego
Co-authored papers
4
Diana Whitehead
Dartmouth-Hitchcock Medical Center
Co-authored papers
4
Gaurav Syal
university of california san diego
Co-authored papers
4
Sunhee Park
University of California Irvine
Co-authored papers
4
1 - 30